Printer Friendly

MEDAPHIS ANNOUNCES SEC EFFECTIVENESS OF COMMON STOCK OFFERING

 ATLANTA, Dec. 2 /PRNewswire/ -- Medaphis Corporation (NASDAQ: MEDA) today announced that its registration statement has been declared effective by the Securities and Exchange Commission relating to the sale of 3,000,000 shares of common stock at a public offering price of $28 per share. Of the total offering, 2,770,601 shares of common stock are being sold by the Company and 229,399 shares of common stock are being sold on behalf of certain of the Company's stockholders. The Company has granted the underwriters an over-allotment option to acquire an additional 450,000 shares of common stock in connection with the offering. The managing underwriters for the offering are Alex. Brown & Sons Incorporated, Bear, Stearns & Co. Inc. and J.C. Bradford & Co.
 Medaphis is a leading provider of business management services, primarily billing and accounts receivable management services to hospital-affiliated physicians and hospitals.
 Copies of the final prospectus are available from Alex. Brown & Sons Incorporated, 135 East Baltimore Street, Baltimore, Maryland 21202; Bear, Stearns & Co. Inc., 245 Park Avenue, New York, New York 10167; and J.C. Bradford & Co., 330 Commerce Street, Nashville, Tennessee 37201.
 This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state.
 -0- 12/2/93
 /CONTACT: Michael R. Cote, chief financial officer of Medaphis, 404-319-3349/
 (MEDA)


CO: Medaphis Corporation ST: Georgia IN: HEA SU: OFR

LG -- NY021 -- 9652 12/02/93 09:11 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Dec 2, 1993
Words:273
Previous Article:BELL ATLANTIC CUSTOMERS TO TEST TEXAS INSTRUMENTS VOICE RECOGNITION TECHNOLOGY
Next Article:ROBERTS PHARMACEUTICAL CORPORATION ANNOUNCES LAUNCH OF NEW U.K. CARDIOVASCULAR DRUG
Topics:

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters